hPG80 at ASCO 2021 - Prolevcan study
Plasma hPG80 circulating prograstin levels in cancer patients in Nigeria: Prolevcan study
top of page
Last Update : 19 may 2020
- Dec 17, 2021
- 3 min
hPG80 at ASCO 2021 - Hepatocellular carcinoma
ASCO Poster Session: Prognostic value of plasma hPG80, alone or in combination with AFP, in patients with hepatocellular carcinoma
- Dec 17, 2021
- 2 min
A Major Publication: The Overexpression of hPG80 (circulating progastrin) in Multiple Cancers
The oncogenic and druggable hPG80 (Progastrin) is overexpressed in multiple cancers and detected in the blood of patients
- Dec 17, 2021
- 1 min
Dr. Aman Chauhan MD (Markey Cancer Center) speaking about hPG80 at #GI ASCO 2020
HPG80 (Progastrin), a novel blood-based biomarker for detection of neuroendocrine neoplasms.
GI ASCO / Presented Friday, January 24, 2020
Search
- Dec 17, 2021
- 2 min
hPG80 at ASCO 2021 - Prolevcan study
Plasma hPG80 circulating prograstin levels in cancer patients in Nigeria: Prolevcan study
- Dec 17, 2021
- 3 min
hPG80 at ASCO 2021 - Hepatocellular carcinoma
ASCO Poster Session: Prognostic value of plasma hPG80, alone or in combination with AFP, in patients with hepatocellular carcinoma
- Dec 17, 2021
- 2 min
A Major Publication: The Overexpression of hPG80 (circulating progastrin) in Multiple Cancers
The oncogenic and druggable hPG80 (Progastrin) is overexpressed in multiple cancers and detected in the blood of patients
- Dec 17, 2021
- 1 min
Dr. Aman Chauhan MD (Markey Cancer Center) speaking about hPG80 at #GI ASCO 2020
HPG80 (Progastrin), a novel blood-based biomarker for detection of neuroendocrine neoplasms.
GI ASCO / Presented Friday, January 24, 2020
bottom of page